Literature DB >> 2519994

Cardiomyoplasty benefits in experimental myocardial dysfunction.

L F Moreira1, A C Chagas, G P Camarano, A Leirner, P M Pêgo-Fernandes, P L da Luz, N A Stolf, A D Jatene.   

Abstract

Beneficial effects of cardiomyoplasty have been documented and the use of this technique in the treatment of dilated cardiomyopathy have been suggested. This study was undertaken to evaluate the effectiveness of stimulated preconditioned latissimus dorsi muscle flaps wrapped around the heart in order to restore ventricular contractility in six adult mongrel dogs with induced myocardial dysfunction by administration of beta blockers and volume loading. Hemodynamic and two-dimensional echocardiographic evaluation were performed 1 week after the surgical procedure and immediately after heart failure induction. With synchronous pulse train electrical stimulation, cardiac output increased from 1.46 +/- 0.13 (+/- SD) to 2.01 +/- 0.16 L/min (p less than 0.01), pulmonary wedge pressure decreased from 15.5 +/- 1.2 to 11.3 +/- 1.6 mmHg (p less than 0.01) and left ventricular end-diastolic pressure from 18.3 +/- 2.4 to 13.5 +/- 1.4 mmHg (p less than 0.04). Echo derived left ventricular ejection fraction increased from 39.3 +/- 2.4 to 59.6 +/- 2.9% (p less than 0.01) and segmental wall shortening from 15.4 +/- 1.2 to 26.3 +/- 1.7% (p less than 0.01), inclusive when the muscle flap was wrapped only around the left ventricle. In conclusion, this study suggests that cardiomyoplasty may be an alternative method of treatment for irreversible cardiomyopathy, including in patients with a great cardiac enlargement in which muscle flap may only be wrapped partially around the heart.

Entities:  

Mesh:

Year:  1989        PMID: 2519994     DOI: 10.1111/j.1540-8191.1989.tb00273.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  4 in total

1.  Cardiomyoplasty.

Authors:  R W Millner; J R Pepper
Journal:  BMJ       Date:  1991-06-08

2.  Skeletal muscle ventricles for total heart replacement.

Authors:  A Pochettino; A D Spanta; R L Hammond; D R Anderson; C R Bridges; P Samet; H Niinami; E Hohenhaus; S Salmons; L W Stephenson
Journal:  Ann Surg       Date:  1990-09       Impact factor: 12.969

3.  First experience with cardiomyoplasty in Ukraine.

Authors:  V V Piluiko; G V Knishov; L G Riabinina; A A Krakovsky
Journal:  Tex Heart Inst J       Date:  1995

Review 4.  [Dynamic cardiomyoplasty].

Authors:  R Lange; M Thielmann; S Hagl
Journal:  Herz       Date:  1997-10       Impact factor: 1.443

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.